Abstract
It is projected that the number of individuals with dementia will continue to increase over the next several decades, with no cure in sight. Consequently, a greater understanding of how to promote behavioral health and quality of life for these individuals is becoming increasingly important. A common approach in the field is symptom management through pharmacologic approaches to cognitive enhancement and treatment of behavioral changes. Rather than a purely medical approach to dementia care, interventions to improve quality of life should involve comprehensive, integrated care. This chapter discusses literature that describes an integrated, contextual model of dementia care, in which comorbid conditions are appropriately treated, adaptive behaviors are supported, and excess disability is rectified or prevented. Within the context of this model of dementia care, the current chapter also describes the importance of family caregiver quality of life and neurocognitive education, in order to improve treatment for individuals suffering from this insidious disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abbott, R. A., Whear, R., Rodgers, L. R., Bethel, A., Coon, J. T., Kuyken, W., … Dickens, C. (2014). Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis of randomised controlled trials. Journal of Psychosomatic Research, 76(5), 341–351.
Abizanda, P., Romero, L., Sanchez-Jurado, P. M., Martinez-Reig, M., Alfonso-Silguero, S. A., & Rodriguez-Manas, L. (2014). Age, frailty, disability, institutionalization, multimorbidity or comorbidity. Which are the main targets in older adults? The Journal of Nutrition, Health & Aging, 18(6), 622.
Achterberg, W. P., Pieper, M. J., van Dalen-Kok, A. H., De Waal, M. W., Husebø, B., Lautenbacher, S., … Corbett, A. (2013). Pain management in patients with dementia. Clinical Interventions in Aging, 8, 1471–1482.
Alexopoulos, G. S. (2005). Depression in the elderly. The Lancet, 365(9475), 1961–1970.
Alliance, F. C. (2012). Fact sheet: Selected caregiver statistics. San Francisco, CA: Family Caregiver Alliance.
American Psychological Association. (2017). Integrated Health Care. Retrieved from http://www.apa.org/health/integrated-health-care.aspx
Andreassi, J. L. (2013). Psychophysiology: Human behavior & physiological response. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.
Baert, V., Gorus, E., Mets, T., Geerts, C., & Bautmans, I. (2011). Motivators and barriers for physical activity in the oldest old: A systematic review. Ageing Research Reviews, 10(4), 464–474.
Ballard, C., Hanney, M. L., Theodoulou, M., Douglas, S., McShane, R., Kossakowski, K., … Jacoby, R. (2009). The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology, 8(2), 151–157.
Ballard, C., Smith, J., Corbett, A., Husebo, B., & Aarsland, D. (2011). The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). International Journal of Palliative Nursing, 17(9), 420–424.
Bandurska, E., Damps-Konstanska, I., Popowski, P., Jedrzejczyk, T., Janowiak, P., Swietnicka, K., … Jassem, E. (2017). Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD). Medical Science Monitor, 23, 2850–2862.
Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., … Graff-Radford, N. (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain Bank. Alzheimer Disease & Associated Disorders, 16(4), 203–212.
Bauman, A., Merom, D., Bull, F. C., Buchner, D. M., & Fiatarone Singh, M. A. (2016). Updating the evidence for physical activity: Summative reviews of the epidemiological evidence, prevalence, and interventions to promote “active aging”. The Gerontologist, 56(Suppl_2), S268–S280.
Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012). Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer disease centers, 2005–2010. Journal of Neuropathology & Experimental Neurology, 71(4), 266–273.
Beerens, H. C., Sutcliffe, C., Renom-Guiteras, A., Soto, M. E., Suhonen, R., Zabalegui, A., … RightTimePlaceCare Consortium. (2014). Quality of life and quality of care for people with dementia receiving long term institutional care or professional home care: The European RightTimePlaceCare study. Journal of the American Medical Directors Association, 15(1), 54–61.
Beerens, H. C., Zwakhalen, S. M., Verbeek, H., Ruwaard, D., & Hamers, J. P. (2013). Factors associated with quality of life of people with dementia in long-term care facilities: A systematic review. International Journal of Nursing Studies, 50(9), 1259–1270.
Bond, M., Rogers, G., Peters, J., Anderson, R., Hoyle, M., Miners, A., … Jeffreys, M. (2012). The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of technology appraisal no. 111): A systematic review and economic model. Health Technology Assessment (Winchester, England), 16(21), 1–470.
Boustani, M., Peterson, B., Hanson, L., Harris, R., & Lohr, K. N. (2003). Screening for dementia in primary care: A summary of the evidence for the US preventive services task force. Annals of Internal Medicine, 138(11), 927–937.
Bowling, A. (2001). Measuring disease. In A review of disease-specific quality of life measurement scales. Buckingham, UK: Open University Press.
Bowling, A., Rowe, G., Adams, S., Sands, P., Samsi, K., Crane, M., … Manthorpe, J. (2015). Quality of life in dementia: A systematically conducted narrative review of dementia-specific measurement scales. Aging & Mental Health, 19(1), 13–31.
Brown, L. G. (2016). Untangling polypharmacy in older adults. Medsurg Nursing, 25(6), 408–412.
Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005). Neurodegenerative diseases: An overview of environmental risk factors. Environmental Health Perspectives, 113(9), 1250–1256.
Buchanan, J. A., Christenson, A., Houlihan, D., & Ostrom, C. (2011). The role of behavior analysis in the rehabilitation of persons with dementia. Behavior Therapy, 42(1), 9–21.
Campanelli, C. M. (2012). American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults: The American Geriatrics Society 2012 beers criteria update expert panel. Journal of the American Geriatrics Society, 60(4), 616.
Catania, A. C. (1996). On the origins of behavior structure. Advances in Psychology, 117, 3–12.
Centers for Medicare & Medicaid Services. (2013). Atypical Antipsychotic Medications: Use in Adults. Retrieved from https://www.cms.gov/medicaremedicaid-coordination/fraud-prevention/medicaid-integrity-education/pharmacy-education-materials/downloads/atyp-antipsych-adult-factsheet.pdf
Chapman, D. P., Williams, S. M., Strine, T. W., Anda, R. F., & Moore, M. J. (2006). Dementia and its implications for public health. Preventing Chronic Disease, 3(2), A34.
Chiu, Y., Bero, L., Hessol, N. A., Lexchin, J., & Harrington, C. (2015). A literature review of clinical outcomes associated with antipsychotic medication use in north American nursing home residents. Health Policy, 119(6), 802–813.
Clague, F., Mercer, S. W., McLean, G., Reynish, E., & Guthrie, B. (2016). Comorbidity and polypharmacy in people with dementia: Insights from a large, population-based cross-sectional analysis of primary care data. Age and Ageing, 46(1), 33–39.
Dawson, P., Wells, D. L., & Kline, K. (1993). Enhancing the abilities of persons with Alzheimer’s and related dementias: A nursing perspective. New York, NY: Springer Publishing Company.
Di Santo, S. G., Prinelli, F., Adorni, F., Caltagirone, C., & Musicco, M. (2013). A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. Journal of Alzheimer’s Disease, 35(2), 349–361.
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L. M. S. W., … Cummings, J. L. (2001). Practice parameter: Management of dementia (an evidence-based review) report of the quality standards Subcommittee of the American Academy of neurology. Neurology, 56(9), 1154–1166.
Dramé, M., Fierobe, F., Lang, P. O., Jolly, D., Boyer, F., Mahmoudi, R., … Voisin, T. (2011). Predictors of institution admission in the year following acute hospitalisation of elderly people. The Journal of Nutrition. Health & Aging, 15(5), 399–403.
Enns, E., Rhemtulla, R., Ewa, V., Fruetel, K., & Holroyd-Leduc, J. M. (2014). A controlled quality improvement trial to reduce the use of physical restraints in older hospitalized adults. Journal of the American Geriatrics Society, 62(3), 541–545.
Fauth, E. B., & Gibbons, A. (2014). Which behavioral and psychological symptoms of dementia are the most problematic? Variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms. International Journal of Geriatric Psychiatry, 29(3), 263–271.
Fisher, J. E., Drossel, C., Yury, C., & Cherup, S. (2007). A contextual model of restraint–free care for persons with dementia. In P. Sturmey (Ed.), Functional analysis in clinical treatment (pp. 211–238). San Diego, CA: Elsevier.
Fleming, R., Goodenough, B., Low, L. F., Chenoweth, L., & Brodaty, H. (2016). The relationship between the quality of the built environment and the quality of life of people with dementia in residential care. Dementia, 15(4), 663–680.
Gallagher-Thompson, D., Tzuang, Y. M., Au, A., Brodaty, H., Charlesworth, G., Gupta, R., … Shyu, Y. I. (2012). International perspectives on nonpharmacological best practices for dementia family caregivers: A review. Clinical Gerontologist, 35(4), 316–355.
Galvin, J. E., & Sadowsky, C. H. (2012). Practical guidelines for the recognition and diagnosis of dementia. The Journal of the American Board of Family Medicine, 25(3), 367–382.
Garrison-Diehn, C., Rummel, C., & Fisher, J. E. (2013). A contextual approach to dementia Care in Alzheimer’s disease. In Case studies in clinical psychological science: Bridging the gap from science to practice (p. 279). Oxford, NY: Oxford University Press.
Geldmacher, D. S. (2003). Alzheimer’s disease: Current pharmacotherapy in the context of patient and family needs. Journal of the American Geriatrics Society, 51(5s2), S289–S295.
Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012). Nonpharmacologic management of behavioral symptoms in dementia. JAMA, 308(19), 2020–2029.
Gitlin, L. N., Winter, L., Dennis, M. P., Hodgson, N., & Hauck, W. W. (2010). A biobehavioral home-based intervention and the Well-being of patients with dementia and their caregivers: The COPE randomized trial. JAMA, 304(9), 983–991.
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., … Le Couteur, D. G. (2012). Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 65(9), 989–995.
Goodarzi, Z. S., Mele, B. S., Roberts, D. J., & Holroyd-Leduc, J. (2017). Depression case finding in individuals with dementia: A systematic review and meta-analysis. Journal of the American Geriatrics Society., 65(5), 937.
Gu, J., Strauss, C., Bond, R., & Cavanagh, K. (2015). How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clinical Psychology Review, 37, 1–12.
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013). Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology, 80(19), 1778–1783.
Hilton, L., Hempel, S., Ewing, B. A., Apaydin, E., Xenakis, L., Newberry, S., … Maglione, M. A. (2017). Mindfulness meditation for chronic pain: Systematic review and meta-analysis. Annals of Behavioral Medicine, 51(2), 199–213.
Holland, J. M., Currier, J. M., & Gallagher-Thompson, D. (2009). Outcomes from the resources for enhancing Alzheimer’s caregiver health (REACH) program for bereaved caregivers. Psychology and Aging, 24(1), 190.
Hovstadius, B., & Petersson, G. (2012). Factors leading to excessive polypharmacy. Clinics in Geriatric Medicine, 29(2), 159–172.
Husebo, B. S., Strand, L. I., Moe-Nilssen, R., BorgeHusebo, S., Aarsland, D., & Ljunggren, A. E. (2008). Who suffers most? Dementia and pain in nursing home patients: A cross-sectional study. Journal of the American Medical Directors Association, 9(6), 427–433.
Jellinger, K. A., & Attems, J. (2011). Prevalence and pathology of dementia with Lewy bodies in the oldest old: A comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders, 31(4), 309–316.
Judge, K. S., Yarry, S. J., Looman, W. J., & Bass, D. M. (2013). Improved strain and psychosocial outcomes for caregivers of individuals with dementia: Findings from project ANSWERS. The Gerontologist, 53(2), 280–292.
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). State of the art review: Assessment and management of behavioral and psychological symptoms of dementia. The BMJ, 350, h369.
Kim, D. H., Brown, R. T., Ding, E. L., Kiel, D. P., & Berry, S. D. (2011). Dementia medications and risk of falls, syncope, and related adverse events: Meta-analysis of randomized controlled trials. Journal of the American Geriatrics Society, 59(6), 1019–1031.
Knapskog, A. B., Barca, M. L., & Engedal, K. (2014). Prevalence of depression among memory clinic patients as measured by the Cornell scale of depression in dementia. Aging & Mental Health, 18(5), 579–587.
Lambert, M. A., Bickel, H., Prince, M., Fratiglioni, L., Von Strauss, E., Frydecka, D., … Reynish, E. L. (2014). Estimating the burden of early onset dementia; systematic review of disease prevalence. European Journal of Neurology, 21(4), 563–569.
Lauche, R., Cramer, H., Dobos, G., Langhorst, J., & Schmidt, S. (2013). A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. Journal of Psychosomatic Research, 75(6), 500–510.
LoGiudice, D., & Watson, R. (2014). Dementia in older people: An update. Internal Medicine Journal, 44(11), 1066–1073.
Looman, W. M., Huijsman, R., Bouwmans-Frijters, C. A., Stolk, E. A., & Fabbricotti, I. N. (2016). Cost-effectiveness of the ‘Walcheren integrated care Model’intervention for community-dwelling frail elderly. Family Practice, 33(2), 154–160.
Lopez, O. L., Becker, J. T., Wahed, A. S., Saxton, J., Sweet, R. A., Wolk, D. A., … Dekosky, S. T. (2009). Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. Journal of Neurology, Neurosurgery & Psychiatry, 80(6), 600–607.
Lwi, S. J., Ford, B. Q., Casey, J. J., Miller, B. L., & Levenson, R. W. (2017). Poor caregiver mental health predicts mortalilty of patients with neurodegenerative disease. Proceedings of the National Academy of Science, 201701597. https://doi.org/10.1073/pnas.1701597114
Marcum, Z. A., Driessen, J., Thorpe, C. T., Gellad, W. F., & Donohue, J. M. (2014). Effect of multiple pharmacy use on medication adherence and drug–drug interactions in older adults with Medicare part D. Journal of the American Geriatrics Society, 62(2), 244–252.
Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry, 72(5), 438–445.
McKhann, G. M., Albert, M. S., & Sperling, R. A. (2012). Changing diagnostic concepts of Alzheimer’s disease. In Alzheimer’s Disease-Modernizing Concept, Biological Diagnosis and Therapy, 28, 115–121 Karger Publishers.
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., … Mohs, R. C. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269.
Molinari, V., Chiriboga, D., Branch, L. G., Cho, S., Turner, K., Guo, J., & Hyer, K. (2010). Provision of psychopharmacological services in nursing homes. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 65(1), 57–60.
Molinari, V. A. (2006). Caregiver burden. In S. M. Lobo Prabhu, V. A. Molinari, & J. W. Lomax (Eds.), Supporting the caregiver in dementia: A guide for health care professionals (pp. 64–81). Baltimore, MD: The Johns Hopkins University Press.
Moss, K., Scogin, F., Di Napoli, E., & Presnell, A. (2012). A self-help behavioral activation treatment for geriatric depressive symptoms. Aging & Mental Health, 16(5), 625–635.
Neufeld, R. R., Libow, L. S., Foley, W. J., Dunbar, J. M., Cohen, C., & Breuer, B. (1999). Restraint reduction reduces serious injuries among nursing home residents. Journal of the American Geriatrics Society, 47(10), 1202–1207.
Norgaard, A., Jensen-Dahm, C., Gasse, C., Hansen, E. S., & Waldemar, G. (2017). Psychotropic polypharmacy in patients with dementia: Prevalence and predictors. Journal of Alzheimer’s Disease, 56(2), 707–716.
Odenheimer, G., Borson, S., Sanders, A. E., Swain-Eng, R. J., Kyomen, H. H., Tierney, S., … Johnson, J. (2013). Quality improvement in neurology dementia management quality measures. Neurology, 81(17), 1545–1549.
Paller, K. A., Creery, J. D., Florczak, S. M., Weintraub, S., Mesulam, M. M., Reber, P. J., ... O’Hara, M. (2015). Benefits of mindfulness training for patients with progressive cognitive decline and their caregivers. American Journal of Alzheimer’s Disease & Other Dementias®, 30(3), 257–267.
Paterson, R. W., Takada, L. T., & Geschwind, M. D. (2012). Diagnosis and treatment of rapidly progressive dementias. Neurology: Clinical Practice, 2(3), 187–200.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia, 9(1), 63–75.
Prince, M., Comas-Herrera, A., Knapp, M., Guerchet, M., & Karagiannidou, M. (2016). World Alzheimer report 2016: Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. London, UK: Alzheimer’s Disease International (ADI).
Rahman, S. (2017). Enhancing health and wellbeing in dementia: A person-centered integrated care approach. London, UK: Jessica Kingsley Publishers.
Riley, K. E., & Kalichman, S. (2015). Mindfulness-based stress reduction for people living with HIV/AIDS: Preliminary review of intervention trial methodologies and findings. Health Psychology Review, 9(2), 224–243.
Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014). Global epidemiology of dementia: Alzheimer’s and vascular types. BioMed Research International, 2014, 8.
Rolland, Y., Pillard, F., Klapouszczak, A., Reynish, E., Thomas, D., Andrieu, S., … Vellas, B. (2007). Exercise program for nursing home residents with Alzheimer’s disease: A 1-year randomized, controlled trial. Journal of the American Geriatrics Society, 55(2), 158–165.
Rush, S. E., & Sharma, M. (2016). Mindfulness-based stress reduction as a stress management intervention for cancer care: A systematic review. Journal of Evidence-Based Complementary & Alternative Medicine., 2156587216661467, 22(2), 348–360.
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 294(15), 1934–1943.
Schultz, R., Belle, S. H., Czaja, S. J., Gitlin, L. N., Wisniewski, S. R., & Ory, M. G. (2003). Introduction to the special section on resources for enhancing Alzheimer’s caregiver health (REACH). Psychology and Aging, 18(3), 357.
Snarski, M., Scogin, F., DiNapoli, E., Presnell, A., McAlpine, J., & Marcinak, J. (2011). The effects of behavioral activation therapy with inpatient geriatric psychiatry patients. Behavior Therapy, 42(1), 100–108.
Snowden, M. B., Atkins, D. C., Steinman, L. E., Bell, J. F., Bryant, L. L., Copeland, C., & Fitzpatrick, A. L. (2015). Longitudinal association of dementia and depression. The American Journal of Geriatric Psychiatry, 23(9), 897–905.
Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S. (2016). Antipsychotic use in dementia: A systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease, 7(5), 229–245.
Tan, C. C., Yu, J. T., Wang, H. F., Tan, M. S., Meng, X. F., Wang, C., … Tan, L. (2014). Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis. Journal of Alzheimer’s Disease, 41(2), 615–631.
Teri, L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Buchner, D. M., Barlow, W. E., … Larson, E. B. (2003). Exercise plus behavioral management in patients with Alzheimer disease: A randomized controlled trial. JAMA, 290(15), 2015–2022.
Thomas, P., Lalloué, F., Preux, P. M., Hazif-Thomas, C., Pariel, S., Inscale, R., … Clément, J. P. (2006). Dementia patients caregivers quality of life: The PIXEL study. International Journal of Geriatric Psychiatry, 21(1), 50–56.
United States Department of Health and Human Services. (2005). Glossary: Definition of restraints. Retrieved from http://www.medicare.gov/Glossary/ShownTerm.asp?Languge=English&term=restraints
U.S. Food and Drug Administration. (2008). Information for Health Care Professionals: Conventional Antipsychotics. Retrieved from https://wayback.archiveit.org/7993/20170722190727/. https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm
van der Spek, K., Gerritsen, D. L., Smalbrugge, M., Nelissen-Vrancken, M. H., Wetzels, R. B., Smeets, C. H., … Koopmans, R. T. (2016). Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. International Psychogeriatrics, 28(10), 1589–1595.
Van Duijn, C. M., Clayton, D. G., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., … Rocca, W. A. (1994). Interaction between genetic and environmental risk factors for Alzheimer’s disease: A reanalysis of case-control studies. Genetic Epidemiology, 11(6), 539–551.
van Hout, H. P., Vernooij-Dassen, M. J., & Stalman, W. A. (2007). Diagnosing dementia with confidence by GPs. Family Practice, 24(6), 616–621.
Vance, D. E., & Struzick, T. C. (2007). Addressing risk factors of cognitive impairment in adults aging with HIV: A social work model. Journal of Gerontological Social Work, 49(4), 51–77.
Vasudev, A., Shariff, S. Z., Liu, K., Burhan, A. M., Herrmann, N., Leonard, S., & Mamdani, M. (2015). Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004–2013. The American Journal of Geriatric Psychiatry, 23(12), 1259–1269.
Villars, H., Oustric, S., Andrieu, S., Baeyens, J. P., Bernabei, R., Brodaty, H., … Frisoni, G. (2010). The primary care physician and Alzheimer’s disease: An international position paper. The Journal of Nutrition, Health & Aging, 14(2), 110–120.
Wang, J., Yu, J. T., Wang, H. F., Meng, X. F., Wang, C., Tan, C. C., & Tan, L. (2014). Pharmacological treatment of neuropsychiatric symptoms in Alzheimer’s disease: A systematic review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry, 86(1), 101–109 jnnp-2014.
Wetzels, R. B., Zuidema, S. U., De Jonghe, J. F. M., Verhey, F. R. J., & Koopmans, R. T. C. M. (2010). Determinants of quality of life in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders, 29(3), 189–197.
World Health Organization. (1997). Measuring quality of life. In Division of mental health and prevention of substance abuse. Geneva, Switzerland: World Health Organization.
Yon, A., & Scogin, F. (2008). Behavioral activation as a treatment for geriatric depression. Clinical Gerontologist, 32(1), 91–103.
Yury, C. A., & Fisher, J. E. (2007). Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Psychotherapy and Psychosomatics, 76(4), 213–218.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Singer, J., Chong, A., Hisaka, R., Fisher, J.E. (2018). Promoting the Behavioral Health of Persons with Neurocognitive Disorders. In: Duckworth, M., O'Donohue, W. (eds) Behavioral Medicine and Integrated Care. Springer, Cham. https://doi.org/10.1007/978-3-319-93003-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-93003-9_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93002-2
Online ISBN: 978-3-319-93003-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)